M

MyoPax

3 employees

MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.

Basic info

Industry

biotechnology research

Sectors

Rare diseases
Biotechnology
Health Care
Muscular dystrophies
Muscle diseases
Muscle Stem Cells
Gene Editing
Muscle regeneration

Date founded

2022

Funding rounds raised

Total raised

$1.3M

from 1 investors over 1 rounds

M

MyoPax raised $1.3M on August 21, 2022

Investors: BioInnovation Institute

FAQ